Skip to main content
Top
Published in: Forensic Toxicology 2/2017

Open Access 01-07-2017 | Original Article

Earwax as an alternative specimen for forensic analysis

Authors: Engy Shokry, Jair Gonzalez Marques, Paulo César Ragazzo, Naiara Zedes Pereira, Nelson Roberto Antoniosi Filho

Published in: Forensic Toxicology | Issue 2/2017

Login to get access

Abstract

In this work, we presented, for the first time, earwax as an alternative forensic specimen for detecting 12 neuropsychotic drugs employing liquid chromatography–tandem mass spectrometry in positive and negative ion modes after straightforward extraction with methanol. The method was validated and standard curves were established by external calibration with correlation coefficients >0.99. All precision, accuracy, matrix effects, extraction recoveries, and carryover were within acceptable limits; limits of quantification were sufficiently low to quantify almost all the samples tested. To confirm the feasibility of the study, earwax specimens were collected from actual patients treated with different combinations of the 12 drugs and analyzed by our method; the 12 drugs could be quantified from the earwax specimens of the users successfully, showing usefulness of earwax specimens, because of its noninvasive sampling and the storage of drug(s) for relatively long time together with its being relatively less contaminated by environmental impurities. This study is pioneering; many detailed studies on earwax as an alternative specimen remain to be explored.
Literature
1.
go back to reference Drummer OH (2010) Forensic toxicology. EXS 100:579–603 Drummer OH (2010) Forensic toxicology. EXS 100:579–603
2.
go back to reference Lum G, Mushlin B (2004) Urine drug testing: approaches to screening and confirmation testing. Lab Med 35:368–373CrossRef Lum G, Mushlin B (2004) Urine drug testing: approaches to screening and confirmation testing. Lab Med 35:368–373CrossRef
3.
go back to reference Humbert L, Hoizey G, Lhermitte M (2014) Drugs involved in drug-facilitated crimes (DFC): analytical aspects: 1—blood and urine. In: Kintz P (ed) Toxicological aspects of drug facilitated crimes. Academic Press, Cambridge, pp 159–180CrossRef Humbert L, Hoizey G, Lhermitte M (2014) Drugs involved in drug-facilitated crimes (DFC): analytical aspects: 1—blood and urine. In: Kintz P (ed) Toxicological aspects of drug facilitated crimes. Academic Press, Cambridge, pp 159–180CrossRef
4.
go back to reference Verstraete AG (2004) Detection times of drugs of abuse in blood, urine, and oral fluid. Ther Drug Monit 26:200–205CrossRefPubMed Verstraete AG (2004) Detection times of drugs of abuse in blood, urine, and oral fluid. Ther Drug Monit 26:200–205CrossRefPubMed
5.
go back to reference de Oliveira CR, Roehsig M, de Almeida R, Rocha W, Yonamine M (2016) Recent advances in chromatographic methods to detect drugs of abuse in alternative biological matrices. Curr Pharm Anal 3:95–109CrossRef de Oliveira CR, Roehsig M, de Almeida R, Rocha W, Yonamine M (2016) Recent advances in chromatographic methods to detect drugs of abuse in alternative biological matrices. Curr Pharm Anal 3:95–109CrossRef
6.
go back to reference Boumba VA, Ziavrou KS, Vougiouklakis T (2006) Hair as a biological indicator, drug use, drug abuse, exposure to environmental toxicants. Int J Toxicol 25:143–163CrossRefPubMed Boumba VA, Ziavrou KS, Vougiouklakis T (2006) Hair as a biological indicator, drug use, drug abuse, exposure to environmental toxicants. Int J Toxicol 25:143–163CrossRefPubMed
7.
go back to reference Levy S, Siqueira LM, Committee on Substance Abuse (2014) Testing for drugs of abuse in children and adolescents. Pediatrics 133:e1798–e1807CrossRefPubMed Levy S, Siqueira LM, Committee on Substance Abuse (2014) Testing for drugs of abuse in children and adolescents. Pediatrics 133:e1798–e1807CrossRefPubMed
8.
go back to reference Prokop-Prigge KA, Thaler E, Wysocki CJ, Preti G (2014) Identification of volatile organic compounds in human cerumen. J Chromatogr B 953:48–52CrossRef Prokop-Prigge KA, Thaler E, Wysocki CJ, Preti G (2014) Identification of volatile organic compounds in human cerumen. J Chromatogr B 953:48–52CrossRef
9.
go back to reference Guest JF, Greener MJ, Robinson AC, Smith AF (2004) Impacted cerumen: composition, production, epidemiology and management. QJM 97:477–488CrossRefPubMed Guest JF, Greener MJ, Robinson AC, Smith AF (2004) Impacted cerumen: composition, production, epidemiology and management. QJM 97:477–488CrossRefPubMed
10.
go back to reference Parnas J, Flachs H, Gram L, Würtz-Jørgensen A (1978) Excretion of antiepileptic drugs in sweat. Acta Neurol Scand 58:197–204CrossRefPubMed Parnas J, Flachs H, Gram L, Würtz-Jørgensen A (1978) Excretion of antiepileptic drugs in sweat. Acta Neurol Scand 58:197–204CrossRefPubMed
11.
go back to reference De Giovanni N, Fucci N (2013) The current status of sweat testing for drugs of abuse: a review. Curr Med Chem 20:545–561PubMed De Giovanni N, Fucci N (2013) The current status of sweat testing for drugs of abuse: a review. Curr Med Chem 20:545–561PubMed
12.
go back to reference Stepanov I, Feuer R, Jensen J, Hatsukami D, Hecht SS (2006) Mass spectrometric quantitation of nicotine, cotinine, and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human toenails. Cancer Epidemiol Biomarkers Prev 15:2378–2383CrossRefPubMed Stepanov I, Feuer R, Jensen J, Hatsukami D, Hecht SS (2006) Mass spectrometric quantitation of nicotine, cotinine, and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human toenails. Cancer Epidemiol Biomarkers Prev 15:2378–2383CrossRefPubMed
13.
go back to reference Perez ER, Knapp JA, Horn CK, Stillman SL, Evans JE, Arfsten DP (2016) Comparison of LC–MS–MS and GC–MS analysis of benzodiazepine compounds included in the drug demand reduction urianalysis program. J Anal Toxicol 40:201–207CrossRefPubMedPubMedCentral Perez ER, Knapp JA, Horn CK, Stillman SL, Evans JE, Arfsten DP (2016) Comparison of LC–MS–MS and GC–MS analysis of benzodiazepine compounds included in the drug demand reduction urianalysis program. J Anal Toxicol 40:201–207CrossRefPubMedPubMedCentral
14.
go back to reference Hu Q, Hou H (2015) Guidance for industry bioanalytical method validation by the food and drug administration. Tobacco smoke exposure biomarkers. CRC Press, Boca Raton, pp 247–264 Hu Q, Hou H (2015) Guidance for industry bioanalytical method validation by the food and drug administration. Tobacco smoke exposure biomarkers. CRC Press, Boca Raton, pp 247–264
15.
go back to reference Kintz P, Marescaux C, Mangin P (1995) Testing human hair for carbamazepine in epileptic patients: is hair investigation suitable for drug monitoring? Hum Exp Toxicol 14:812–815CrossRefPubMed Kintz P, Marescaux C, Mangin P (1995) Testing human hair for carbamazepine in epileptic patients: is hair investigation suitable for drug monitoring? Hum Exp Toxicol 14:812–815CrossRefPubMed
17.
go back to reference Kłys M, Rojek S, Bolechała F (2005) Determination of oxcarbazepine and its metabolites in postmortem blood and hair by means of liquid chromatography with mass detection (HPLC/APCI/MS). J Chromatogr B 825:38–46CrossRef Kłys M, Rojek S, Bolechała F (2005) Determination of oxcarbazepine and its metabolites in postmortem blood and hair by means of liquid chromatography with mass detection (HPLC/APCI/MS). J Chromatogr B 825:38–46CrossRef
18.
go back to reference Hosseini SH, Ahmadi A (2015) Abuse potential of carbamazepine for euphorigenic effects. Drug Res 65:223–224 Hosseini SH, Ahmadi A (2015) Abuse potential of carbamazepine for euphorigenic effects. Drug Res 65:223–224
19.
go back to reference Jessen K (2004) Recreational use of phenytoin, marijuana, and alcohol: a case report. Neurology 62:2330CrossRefPubMed Jessen K (2004) Recreational use of phenytoin, marijuana, and alcohol: a case report. Neurology 62:2330CrossRefPubMed
20.
go back to reference Darke S (1994) Benzodiazepine use among injecting drug users: problems and implications. Addiction 89:379–382CrossRefPubMed Darke S (1994) Benzodiazepine use among injecting drug users: problems and implications. Addiction 89:379–382CrossRefPubMed
21.
go back to reference Buckley NA, Whyte IM, Dawson AH (2012) Self-poisoning with lamotrigine. J Anal Toxicol 36:422–428CrossRef Buckley NA, Whyte IM, Dawson AH (2012) Self-poisoning with lamotrigine. J Anal Toxicol 36:422–428CrossRef
22.
go back to reference Bishop-Freeman SC, Kornegay NC, Winecker RE (2012) Postmortem levetiracetam (Keppra®) data from North Carolina. J Anal Toxicol 36:422–428CrossRefPubMed Bishop-Freeman SC, Kornegay NC, Winecker RE (2012) Postmortem levetiracetam (Keppra®) data from North Carolina. J Anal Toxicol 36:422–428CrossRefPubMed
23.
go back to reference Cheze M, Villain M, Pepin G (2004) Determination of bromazepam, clonazepam and metabolites after a single intake in urine and hair by LC–MS/MS. Application to forensic cases of drug facilitated crimes. Forensic Sci Int 145:123–130CrossRefPubMed Cheze M, Villain M, Pepin G (2004) Determination of bromazepam, clonazepam and metabolites after a single intake in urine and hair by LC–MS/MS. Application to forensic cases of drug facilitated crimes. Forensic Sci Int 145:123–130CrossRefPubMed
24.
go back to reference Frison G, Favretto D, Tedeschi L, Ferrara SD (2003) Detection of thiopental and pentobarbital in head and pubic hair in a case of drug-facilitated sexual assault. Forensic Sci Int 133:171–174CrossRefPubMed Frison G, Favretto D, Tedeschi L, Ferrara SD (2003) Detection of thiopental and pentobarbital in head and pubic hair in a case of drug-facilitated sexual assault. Forensic Sci Int 133:171–174CrossRefPubMed
25.
go back to reference Kintz P, Tracqui A, Jamey C, Mangin P (1996) Detection of codeine and phenobarbital in sweat collected with a sweat patch. J Anal Toxicol 20:197–201CrossRefPubMed Kintz P, Tracqui A, Jamey C, Mangin P (1996) Detection of codeine and phenobarbital in sweat collected with a sweat patch. J Anal Toxicol 20:197–201CrossRefPubMed
26.
go back to reference Cirimele V, Kintz P, Gosselin O, Ludes B (2000) Clozapine dose-concentration relationships in plasma, hair and sweat specimens of schizophrenic patients. Forensic Sci Int 107:289–300CrossRefPubMed Cirimele V, Kintz P, Gosselin O, Ludes B (2000) Clozapine dose-concentration relationships in plasma, hair and sweat specimens of schizophrenic patients. Forensic Sci Int 107:289–300CrossRefPubMed
Metadata
Title
Earwax as an alternative specimen for forensic analysis
Authors
Engy Shokry
Jair Gonzalez Marques
Paulo César Ragazzo
Naiara Zedes Pereira
Nelson Roberto Antoniosi Filho
Publication date
01-07-2017
Publisher
Springer Japan
Published in
Forensic Toxicology / Issue 2/2017
Print ISSN: 1860-8965
Electronic ISSN: 1860-8973
DOI
https://doi.org/10.1007/s11419-017-0363-z

Other articles of this Issue 2/2017

Forensic Toxicology 2/2017 Go to the issue